The Clorox Company (NYSE:CLX) Receives $147.06 Average Price Target from Brokerages

The Clorox Company (NYSE:CLX) has been assigned a consensus rating of “Reduce” from the fifteen brokerages that are currently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a sell rating and eleven have given a hold rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $148.00.

Several brokerages have weighed in on CLX. DA Davidson restated a “neutral” rating and set a $162.00 price objective on shares of Clorox in a research note on Monday, February 5th. Bank of America raised Clorox from an “underperform” rating to a “neutral” rating and raised their target price for the company from $120.00 to $150.00 in a research report on Friday, December 15th. StockNews.com raised Clorox from a “sell” rating to a “hold” rating in a research report on Thursday, December 7th. JPMorgan Chase & Co. raised their target price on Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research report on Thursday, January 18th. Finally, UBS Group raised their target price on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, February 2nd.

Clorox Price Performance

Shares of CLX opened at $146.55 on Tuesday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The business’s fifty day moving average is $151.53 and its 200 day moving average is $140.98. Clorox has a 12-month low of $114.68 and a 12-month high of $178.21. The stock has a market cap of $18.19 billion, a P/E ratio of 233.07, a P/E/G ratio of 2.32 and a beta of 0.43.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period last year, the business earned $0.98 EPS. The business’s revenue was up 16.0% on a year-over-year basis. Sell-side analysts anticipate that Clorox will post 5.51 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a dividend of $1.20 per share. This represents a $4.80 dividend on an annualized basis and a yield of 3.28%. The ex-dividend date is Tuesday, April 23rd. Clorox’s payout ratio is presently 761.92%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in CLX. CIBC Private Wealth Group LLC increased its position in shares of Clorox by 0.5% in the fourth quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after purchasing an additional 66 shares during the last quarter. GHP Investment Advisors Inc. raised its position in shares of Clorox by 1.3% during the 4th quarter. GHP Investment Advisors Inc. now owns 5,132 shares of the company’s stock valued at $720,000 after buying an additional 66 shares in the last quarter. Toroso Investments LLC raised its position in shares of Clorox by 1.3% during the 1st quarter. Toroso Investments LLC now owns 5,266 shares of the company’s stock valued at $833,000 after buying an additional 68 shares in the last quarter. First National Bank of Mount Dora Trust Investment Services raised its position in shares of Clorox by 3.2% during the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after buying an additional 71 shares in the last quarter. Finally, Modera Wealth Management LLC raised its position in shares of Clorox by 1.4% during the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after buying an additional 71 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.